
A type of prostate cancer is able to resist conventional hormone ablation therapy by activating a survival cell-signaling pathway, say researchers from UCLA?s Jonsson Comprehensive Cancer Center, Los Angeles.

A type of prostate cancer is able to resist conventional hormone ablation therapy by activating a survival cell-signaling pathway, say researchers from UCLA?s Jonsson Comprehensive Cancer Center, Los Angeles.

Urologists saw their median compensation drop by 4.66% in 2010, recent survey results indicate.

Men with prostate cancer who smoke have an associated increased risk of all-cause, cardiovascular, and prostate cancer-specific death, say the authors of a study from the Harvard School of Public Health, Boston.

Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with active surveillance, say researchers from Thomas Jefferson University and Hospital, Philadelphia.

Current research suggests that the rate of infectious complications, including sepsis, after transrectal prostate needle biopsy may be increasing, and urologists need to be aware of this trend, the AUA said in a recent statement.

A new iPhone application, launched June 2 at the American Society of Clinical Oncology annual meeting in Chicago, is designed to give physicians a quick reference guide for preserving the fertility of children, women, and men diagnosed with cancer.

Reduced amounts of sleep drastically lower a healthy young man?s testosterone levels, according to a recent study published as a research letter in JAMA (2011; 305: 2173-4).

Brisk walking may lower the risk of prostate cancer progression, according to researchers at the University of California, San Francisco and the Harvard School of Public Health, Boston.

Higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective in patients with low- to intermediate-risk prostate cancer, say the authors of a multicenter study.

In March 2011, urologists united their voices once again in Washington at the 6th Annual Joint Advocacy Conference (JAC).

Christopher Kane, MD, has been named the inaugural holder of the C. Lowell and JoEllen Parsons Endowed Chair in Urology at the University of California, San Diego.

Pelvic organ prolapse appears to be caused by a combination of a loss of elasticity and a breakdown of proteins in the vaginal wall, according to a recent multicenter study.

A still-investigational prostate cancer test that measures PSA as well as six specific antibodies found in the blood of men with the disease is more sensitive and more specific than the conventional PSA test, say researchers from UCLA?s Jonsson Comprehensive Cancer Center.

Implementation of comprehensive tort reform has been associated with a nearly 80% decrease in the prevalence of surgical malpractice lawsuits at one academic medical center, say researchers from the University of Texas Health Science Center in San Antonio.

Men who regularly drink coffee appear to have a lower risk of developing a lethal form of prostate cancer, according to a recent multicenter study.

A PSA test taken for the first time between the ages of 44 and 50 years can predict the likelihood that a man will die from prostate cancer over the next 25 to 30 years, according to researchers at Memorial Sloan-Kettering Cancer Center, New York.

A substantial proportion of patients over age 65 years with newly diagnosed prostate cancer are not being treated according to existing guidelines for imaging in this setting.

The Medicare Payment Advisory Commission has made recommendations to Congress that, if implemented, would limit or reduce payments to urologists for in-office imaging services.

Among men receiving early androgen deprivation therapy for biochemical recurrence after radical prostatectomy, obesity appears to be a significant risk factor for poorer prognosis.

Tubularized urethras can be engineered from autologous cells and used successfully in the reconstruction of complex posterior urethral defects in children to maintain function long-term.

Urologists say they don't have time to participate in blogs, but some do embrace the medium.

Percutaneous tibial nerve stimulation is not a cost-effective means of treating overactive bladder as a primary intervention, but cost is not the only factor to consider when confronting OAB, and cost alone may not be a sufficient reason to avoid the therapy.

A prospective, randomized, double-blind study comparing postoperative pain between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy appears to favor the robotic technique.

It's d?j? vu all over again with physician-hospital affiliations emerging across the country.

The non-medical use of prescription drugs is thought to represent the fastest growing drug problem in the United States, and urologists aren't immune to it.

Prostate cancer risk declines significantly in men who have a favorably low calcium-absorption genotype and low calcium intake.

The Patient Protection and Affordable Care Act, the new health care reform law, takes some "paltry steps" toward improving the quality of medical care, but it ignores the most fundamental problem that still begs for a solution-how to fairly compensate physicians who treat Medicare patients.

It is important to be cautious when discarding important documents that could be required by the IRS in the event of an audit or would enable you to collect a future refund should you need to file an amended tax return.

Updated phase III clinical trial results provide further evidence that oral abiraterone acetate (ZYTIGA), which was recently approved by the FDA, is well tolerated and has significant clinical benefit in men failing previous intervention for metastatic castration-resistant prostate cancer.

Women with IC symptoms are not getting the diagnosis and treatment they need, despite serious effects on quality of life.